dorsaVi Pty Ltd – Trademark Portfolio

Entity Type: 99

dorsaVi Pty Ltd holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending. The owner is based in MELBOURNE EAST.

120 Jolimont Road

Level 1

MELBOURNE EAST VIC 3002 , AU

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

dorsaVi Pty Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (5 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does dorsaVi Pty Ltd have?

dorsaVi Pty Ltd has 5 U.S. trademarks filed with the USPTO. Of these, 1 pending, 1 cancelled.

What trademark classes does dorsaVi Pty Ltd file in?

dorsaVi Pty Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What is dorsaVi Pty Ltd's trademark registration success rate?

dorsaVi Pty Ltd has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.